Trials / Conditions / Gastric Cancer Adenocarcinoma Metastatic

Gastric Cancer Adenocarcinoma Metastatic

10 registered clinical trials studyying Gastric Cancer Adenocarcinoma Metastatic — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer NCT06962137	Universitaire Ziekenhuizen KU Leuven	Phase 2
Recruiting	Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Seco NCT07392346	Dai, Guanghai	Phase 2
Recruiting	Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignan NCT07149090	Asan Medical Center	Phase 1 / Phase 2
Recruiting	A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer NCT06921837	Bolt Biotherapeutics, Inc.	Phase 1 / Phase 2
Enrolling By Invitation	AI-Based Prediction of Lymph Node Metastasis in Gastric Cancer Using Preoperative Multimodal Data NCT06957678	Qun Zhao	—
Not Yet Recruiting	Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors NCT06730581	Beijing Biostar Pharmaceuticals Co., Ltd.	Phase 2
Recruiting	Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric NCT06711471	LIN YANG	Phase 2
Recruiting	The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with NCT06702683	Lin Liu	—
Completed	Conversion Effects of PD-1 Antibody Camrelizumab Combined With Nab-POF Regimen Chemotherpy in Patients With In NCT04510064	Fudan University	Phase 2
Completed	Docetaxel+Oxali+/-Cetux Met Gastric/GEJ NCT00517829	US Oncology Research	Phase 2